Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,666,646
  • Shares Outstanding, K 38,982
  • Annual Sales, $ 125,600 K
  • Annual Income, $ -2,027 M
  • EBIT $ -547 M
  • EBITDA $ 1,029 M
  • 60-Month Beta 4.52
  • Price/Sales 23.19
  • Price/Cash Flow 3.43
  • Price/Book 1.59

Options Overview Details

View History
  • Implied Volatility 85.85% (+0.31%)
  • Historical Volatility 83.74%
  • IV Percentile 20%
  • IV Rank 19.90%
  • IV High 161.34% on 02/14/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 14) 11.97 (11.96%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 537
  • Volume Avg (30-Day) 1,428
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 26,083
  • Open Int (30-Day) 30,301
  • Expected Range 88.10 to 112.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -3.33
  • Number of Estimates 1
  • High Estimate -3.33
  • Low Estimate -3.33
  • Prior Year -1.86
  • Growth Rate Est. (year over year) -79.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.00 +7.60%
on 01/20/26
118.84 -15.79%
on 01/22/26
-3.91 (-3.76%)
since 01/06/26
3-Month
74.00 +35.23%
on 11/07/25
118.84 -15.79%
on 01/22/26
+20.01 (+24.99%)
since 11/06/25
52-Week
20.44 +389.58%
on 04/07/25
118.84 -15.79%
on 01/22/26
+67.08 (+203.33%)
since 02/06/25

Most Recent Stories

More News
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening

GRAL : 100.07 (+6.39%)
The Most Expensive Question Investors Ask

A clear framework for knowing when to cut losses and when structure makes averaging down the right move.

PYPL : 40.42 (+1.30%)
SNDK : 597.95 (+3.77%)
ILMN : 119.72 (-10.40%)
WDC : 282.58 (+8.61%)
GRAL : 100.07 (+6.39%)
GE : 321.00 (+4.78%)
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025

These three stocks started 2025 small, but graduated to mid-cap territory after +300% gains. See what caused their rise, and what analysts are forecasting.

GRAL : 100.07 (+6.39%)
VSAT : 41.70 (+11.38%)
PL : 22.26 (+8.96%)
ASTS : 101.79 (+9.13%)
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif. , Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 100.07 (+6.39%)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MENLO PARK, Calif. , Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted...

GRAL : 100.07 (+6.39%)
Why GRAIL Stock Could Be Biotech’s Next Big Breakout

Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.

GRAL : 100.07 (+6.39%)
MRK : 121.93 (+1.82%)
JNJ : 239.99 (+0.93%)
PFE : 27.22 (+2.76%)
BMY : 61.99 (+4.15%)
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

MENLO PARK, Calif. , Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 100.07 (+6.39%)
GRAIL Reports Third Quarter 2025 Financial Results

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million

GRAL : 100.07 (+6.39%)
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

MENLO PARK, Calif. , Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 100.07 (+6.39%)
GRAIL to Announce Third Quarter 2025 Financial Results

Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13 th

GRAL : 100.07 (+6.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 106.06
2nd Resistance Point 103.54
1st Resistance Point 101.80
Last Price 100.07
1st Support Level 97.54
2nd Support Level 95.02
3rd Support Level 93.28

See More

52-Week High 118.84
Last Price 100.07
Fibonacci 61.8% 81.25
Fibonacci 50% 69.64
Fibonacci 38.2% 58.03
52-Week Low 20.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar